Literature DB >> 23032445

F2-isoprostanes: an emerging pulmonary arterial hypertension biomarker and potential link to the metabolic theory of pulmonary arterial hypertension?

Peter Dromparis1, Evangelos D Michelakis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23032445     DOI： 10.1378/chest.12-0848

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension.

Authors:  Robert A Egnatchik; Evan L Brittain; Amy T Shah; Wassim H Fares; H James Ford; Ken Monahan; Christie J Kang; Emily G Kocurek; Shijun Zhu; Thong Luong; Thuy T Nguyen; Erik Hysinger; Eric D Austin; Melissa C Skala; Jamey D Young; L Jackson Roberts; Anna R Hemnes; James West; Joshua P Fessel
Journal:  Pulm Circ       Date:  2017-02-01       Impact factor: 3.017

Review 2.  An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers.

Authors:  Joana Santos-Gomes; Inês Gandra; Rui Adão; Frédéric Perros; Carmen Brás-Silva
Journal:  Front Cardiovasc Med       Date:  2022-07-14

Review 3.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.